COMPLEX DYSTONIA OF PARKINSONS-DISEASE - CLINICAL-FEATURES AND RELATION TO PLASMA LEVODOPA PROFILE

被引:26
|
作者
MCHALE, DM [1 ]
SAGE, JI [1 ]
SONSALLA, PK [1 ]
VITAGLIANO, D [1 ]
机构
[1] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT NEUROL,CN 19,NEW BRUNSWICK,NJ 08903
关键词
Chorea; Dystonia; Parkinson's disease; Plasma levodopa profile;
D O I
10.1097/00002826-199004000-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We studied the clinical characteristics and plasma levodopa (LD) profile of complex, LD-associated dystonia in 33 patients with Parkinson's disease (PD). Generalized, abdominal, respiratory, and myoclonic, but not facial or foot, dystonia could be related to specific phases of the plasma LD cycle. Simultaneous clinical observation and determinations of plasma LD concentrations were often necessary to find the most efficacious dosing schedule for these patients. Maintenance of steady plasma LD concentrations within a dystonia-free window of benefit was the best treatment.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 50 条
  • [31] PIGMENTATION IN PARKINSONS-DISEASE TREATED WITH LEVODOPA
    GRAINGER, KM
    [J]. LANCET, 1973, 1 (7794): : 97 - 98
  • [32] FLUCTUATING LEVODOPA CONCENTRATIONS AND PARKINSONS-DISEASE
    JUNCOS, J
    SERRATI, C
    FABBRINI, G
    CHASE, TN
    [J]. LANCET, 1985, 2 (8452): : 440 - 440
  • [33] BROMOCRIPTINE IN LIEU OF LEVODOPA FOR PARKINSONS-DISEASE
    WODAK, J
    STARK, R
    GILLIGAN, B
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1978, 2 : 28 - 31
  • [34] PROGRESSION OF PARKINSONS-DISEASE WITHOUT LEVODOPA
    GOETZ, CG
    TANNER, CM
    SHANNON, KM
    [J]. NEUROLOGY, 1987, 37 (04) : 695 - 698
  • [35] METABOLIC PATTERNS AND CLINICAL RESPONSE TO LEVODOPA THERAPY IN PARKINSONS-DISEASE
    MESSIHA, FS
    KNOPP, W
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1973, 14 (04) : 565 - 571
  • [36] LEVODOPA IN PARKINSONS-DISEASE - EFFECT ON MORTALITY
    MARTTILA, RJ
    RINNE, UK
    SONNINEN, V
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1984, 69 : 45 - 46
  • [37] TRANSIENT LEVODOPA WITHDRAWAL IN PARKINSONS-DISEASE
    MAESNER, JE
    [J]. CLINICAL PHARMACY, 1987, 6 (01): : 22 - 22
  • [38] CLINICAL, NEUROPSYCHOLOGICAL AND HEMODYNAMIC-EFFECTS OF LEVODOPA IN PARKINSONS-DISEASE
    MONTASTRUC, JL
    CELSIS, P
    DEMONET, JF
    AGNIEL, A
    VIALLARD, G
    RASCOL, A
    MARCVERGNES, JP
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (05) : P617 - P617
  • [39] ROPINIROLE WITHOUT LEVODOPA IN PARKINSONS-DISEASE
    VIDAILHET, MJ
    BONNET, AM
    BELAL, S
    DUBOIS, B
    MARLE, C
    AGID, Y
    [J]. LANCET, 1990, 336 (8710): : 316 - 317
  • [40] LEVODOPA CHALLENGE TEST IN PARKINSONS-DISEASE
    STEIGER, MJ
    QUINN, NP
    [J]. LANCET, 1992, 339 (8795): : 751 - 752